HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Araki Selected Research

Alzheimer Disease (Alzheimer's Disease)

1/2001Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Araki Research Topics

Disease

7Type 2 Diabetes Mellitus (MODY)
01/2016 - 06/2000
3Insulin Resistance
04/2008 - 08/2002
3Brain Injuries (Brain Injury)
10/2001 - 07/2000
2Hepatocellular Carcinoma (Hepatoma)
11/2003 - 01/2001
2Obesity
02/2003 - 08/2002
2Inflammation (Inflammations)
10/2001 - 01/2001
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2016
1Nasopharyngitis
10/2015
1Body Weight (Weight, Body)
10/2015
1Weight Gain
04/2013
1Frostbite
11/2008
1Pain (Aches)
11/2008
1Necrosis
11/2008
1Fabry Disease (Fabry's Disease)
10/2005
1Carcinogenesis
11/2001
1Neoplasms (Cancer)
11/2001
1Brain Ischemia (Cerebral Ischemia)
10/2001
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2001
1Alzheimer Disease (Alzheimer's Disease)
01/2001
1Osteoarthritis
01/2001
1Type 1 Maturity-Onset Diabetes of the Young
07/2000
1Albuminuria
06/2000
1Diabetes Complications
06/2000
1Myoclonus (Nocturnal Myoclonus)
05/2000
1Hyperemia
01/2000
1Hypercapnia
01/2000

Drug/Important Bio-Agent (IBA)

3Insulin (Novolin)FDA Link
11/2003 - 06/2000
2voglibose (Basen)IBA
04/2013 - 04/2012
2LinagliptinIBA
04/2013 - 04/2012
2Insulin ReceptorIBA
08/2002 - 01/2001
2EnzymesIBA
10/2001 - 01/2001
2Glutamic Acid (Glutamate)FDA Link
10/2001 - 01/2001
2ProstaglandinsIBA
10/2001 - 01/2001
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2001 - 01/2000
1NAD (NADH)IBA
01/2016
1Glucagon-Like Peptide-1 ReceptorIBA
10/2015
1BiguanidesIBA
10/2015
1dulaglutideIBA
10/2015
1Insulin Glargine (Lantus)FDA Link
10/2015
1empagliflozinIBA
07/2015
1IceIBA
11/2008
1Mitochondrial DNA (mtDNA)IBA
04/2008
1GalactosidasesIBA
10/2005
1alpha-Galactosidase (Beano)IBA
10/2005
1Proteins (Proteins, Gene)FDA Link
11/2003
1Hormones (Hormone)IBA
02/2003
1ResistinIBA
02/2003
1Peptides (Polypeptides)IBA
02/2003
1Aurothioglucose (Gold 50)IBA
08/2002
1Glucose (Dextrose)FDA LinkGeneric
08/2002
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2001
1Glutathione Transferase (Glutathione S-Transferase)IBA
11/2001
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2001
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2001
1CytokinesIBA
09/2001
1N-Methylaspartate (NMDA)IBA
01/2001
1Trans-Activators (Trans-Acting Factor)IBA
01/2001
1ElementsIBA
01/2001
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2000
1Transcription Factors (Transcription Factor)IBA
07/2000
1serum P-component (CIt)IBA
06/2000
1TolueneIBA
05/2000
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
01/2000
1BradykininIBA
01/2000
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2000

Therapy/Procedure

2Therapeutics
07/2015 - 06/2000
1Enzyme Replacement Therapy
10/2005
1Renal Dialysis (Hemodialysis)
10/2005
1Light Coagulation
06/2000